Blog Omnicell Sterile Compounds 
Omnicell
JANUARY 10, 2023
And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.
Omnicell
SEPTEMBER 5, 2022
Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. billion in associated costs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.
Omnicell
SEPTEMBER 5, 2022
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.
Omnicell
SEPTEMBER 5, 2022
David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.
Omnicell
FEBRUARY 17, 2023
Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. A new era of IV robotics in the IVX Station , new technology introduced as part of Omnicell's Winter 2022 Release.
Omnicell
JANUARY 10, 2023
Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Read more about the Omnicell-AHN Partnership in this week’s press release. Subscribe today.
Expert insights. Personalized for you.
93 
Let's personalize your content